Library

Autor(en) Titel Quelle Links
Machatschek JN, Paulussen M, Bielack S Chemotherapie bei malignen Knochentumoren. Buchbeitrag 2005    
Mack JW, Hilden JM, Watterson J, Moore C, Turner B, Grier HE, Weeks JC, Wolfe J Parent and physician perspectives on quality of care at the end of life in children with cancer. Journal of clinical oncology 2005, 23: 9155    
MacDonald TJ, Aguilera D, Kramm CM Treatment of high-grade glioma in children and adolescents. Neuro Oncol 2011, [Epub ahead of print]    
Magrath IT African Burkitt's lymphoma: History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol 1991, 13: 222    
McMahon AD, Conway DI, Macdonald TM, McInnes GT The unintended consequences of clinical trials regulations. PLoS medicine 2009, 3:e1000131    
Mahmood L The metabolic processes of folic acid and Vitamin B12 deficiency. J Health Res Rev 2014, 1: 5 - 9    
Maigne G, Ferlicot S, Galacteros F, Belenfant X, Ulinski T, Niaudet P, Ronco P, Godeau B, Durrbach A, Sahali S, Lang P, Lambotte O, Audard V Glomerular lesions in patients with sickle cell disease. Medicine 2010, 89: 18    
Majumdar S, Thompson W, Ahmad N, Gordon C, Addison C The use and effectiveness of complementary and alternative medicine for pain in sickle cell anemia. Complementary therapies in clinical practice 2013, 19: 184    
Makarova O, Oschlies I, Mueller S, Ruf S, Zimmermann M, Niggli F, Attarbaschi A, Kabickova E, Klapper W, Woessmann W, Burkhardt B Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma. British journal of haematology 2018, 182: 735    
Mallick AA, Ganesan V, Kirkham FJ, Fallon P, Hedderly T, McShane T, Parker AP, Wassmer E, Wraige E, Amin S, Edwards HB, Tilling K, O'Callaghan FJ Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study. Lancet Neurol. 2014, 13: 35    
Mann G, Reinhardt D, Ritter J, Hermann J, Schmitt K, Gadner H, Creutzig U Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Annals Hematology 2001, 80: 417    
Manzke O, Russello O, Leenen C, Diehl V, Bohlen H, Berthold F Immunotherapeutic strategies in neuroblastoma. Med Pediatr Oncol 2001, 36: 185    
Mann G, Cazzaniga G, van der Velden VH, Flohr T, Csinady E, Paganin M, Schrauder A, Dohnal AM, Schrappe M, Biondi A, Gadner H, van Dongen JJ, Panzer-Grümayer ER Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease? Leukemia 2007, 21: 642    
Mann G, Attarbaschi A, Burkhardt B, Niggli F, Klapper W, Ludwig WD, Schrappe M, Zimmermann M, Gadner H, Reiter A, Berlin-Frankfurt-Münster Group Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma. British journal of haematology 2007, 139: 443    
Mannhalter Ch Molekularbiologie und Hämostase. Hämostaseologie 2008, 28: 272    
Manola KN Cytogenetics of pediatric acute myeloid leukemia. European journal of haematology 2009, 83: 391    
Mann G, Attarbaschi A, Schrappe M, De Lorenzo P, Peters C, Hann I, De Rossi G, Felice M, Lausen B, Leblanc T, Szczepanski T, Ferster A, Janka-Schaub G, Rubnitz J, Silverman LB, Stary J, Campbell M, Li CK, Suppiah R, Biondi A, Vora A, Valsecchi MG, Pieters R Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukaemia: results from the Interfant-99 Study. Blood 2010 Jun 30; [Epub ahead of print]    
Manwani D, Frenette PS Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood 2013, 122: 3892    
Martinez-Climent JA, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R, Murphy SB, Vardiman JW, Larson RA, Le Beau MM et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia. Leukemia 1995, 9: 95    
Marymont MH, Geohas J, Tomita T, Strauss L, Brand WN, Mittal BB Hyperfractionated craniospinal radiation in medulloblastoma. Pediatric neurosurgery 1996, 24: 178    
Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA, Brodeur GM Molecular genetic analysis of familial neuroblastoma. European journal of cancer (Oxford, England : 1990) 1997, 33: 1923    
Marx M, Langer T, Beck J, Dörr H Disorders of endocrine function after brain tumor therapy in childhood. Strahlenther Onkol 1999, 175: 305    
Marx M, Schoof E, Grabenbauer G, Beck J, Dörr H Effects of puberty on bone age maturation in a girl after medulloblastoma therapy. J Pediatr Adolesc Gynecol 1999, 12: 62    
Marx M, Beck J, Müller H, Kühl J, Langer T, Dörr H Endocrine late-effects of brain tumour therapy in childhood and adolescence. Klin Pädiatr 2000, 212: 224    
Marx M, Beck J, Grabenbauer G, Dörr H Spontaneous nocturnal growth hormone secretion in children after medulloblastoma therapy. Med Pediatr Oncol 2001, 36: 494    
Marx M, Langer T, Graf N, Hausdorf G, Stohr W, Ludwig R, Beck J Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No. 9/GPOH and SIOP 93-01/GPOH. Med Pediatr Oncol 2002, 39: 18    
Marx M, Langer T, Graf N, Hausdorf G, Stohr W, Ludwig R, Beck J Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No. 9/GPOH and SIOP 93-01/GPOH*. Med Pediatr Oncol 2002, 39: 18    
Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Fernández-Viña M, Geraghty DE, Holdsworth R, Hurley CK, Lau M, Lee KW, Mach B, Maiers M, Mayr WR, Müller CR, Parham P, Petersdorf EW, Sasazuki T, Strominger JL, Svejgaard A, Terasaki PI, Tiercy JM, Trowsdale J An update to HLA Nomenclature, 2010. Bone marrow transplantation 2010, 45: 846    
Maris JM Recent advances in neuroblastoma. The New England journal of medicine 2010 Jun 10; 362: 2202    
Maroz A, Stachorski L, Emmrich S, Reinhardt K, Xu J, Shao Z, Käbler S, Dertmann T, Hitzler J, Roberts I, Vyas P, Juban G, Hennig C, Hansen G, Li Z, Orkin S, Reinhardt D, Klusmann JH GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia. Leukemia 2014, 28: 1259    
Marina N, Smeland S, Bielack S, Bernstein M, Jovic G, Krailo M, Hook J, Arndt C, van den Berg H, Brennan B, Brichard B, Brown K, Butterfass-Bahloul T, Calaminus G, Daldrup-Link H, Erksson M, Gebhardt M, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier H, Hale J, Hall K, Hardes J, Hawkins D, Helmke K, Hogendoorn P, Isakoff M, Janeway K, Jürgens H, Kager L, Kühne T, Lau C, Leavey P, Lessnick S, Mascarenhas L, Meyers P, Mottl H, Nathrath M, Papai Z, Randall R, Reichardt P, Renard M, Safwat A, Schwartz C, Stevens M, Strauss S, Teot L, Werner M, Sydes M, Whelan J Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial . Lancet Oncol 2016, 17: 1396    
Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, Riva D, Ruggiero A, Valentini L, Mazza E, Genitori L, Di Rocco C, Navarria P, Casanova M, Ferrari A, Luksch R, Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 2002, 20: 4209    
Masera G, Eden T, Schrappe M, Nachman J, Gadner H, Gaynon P, Evans W, Pui C Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia. Pediatr Blood Cancer 2004, 43: 103    
Masjosthusmann K, Bielack SS, Kohler G, Florax A, Schiborr M, Bruch J, Reinhardt D, Kuhn N, Paulussen M, Jürgens H Concomitant Ewing sarcoma and acute lymphoblastic leukemia in a 5-year-old girl. Pediatric blood & cancer 2005, 45: 846    
Masoudi A, Elopre M, Amini E, Nagel ME, Ater JL, Gopalakrishnan V, Wolff JE Influence of valproic acid on outcome of high-grade gliomas in children. Anticancer Res 2008, 28: 2437    
Massimino M, Giangaspero F, Garrè ML, Gandola L, Poggi G, Biassoni V, Gatta G, Rutkowski S Childhood medulloblastoma. Crit Rev Oncol Hematol 2010, Epub ahead of print    
Masqué-Soler N, Szczepanowski M, Leuschner I, Vokuhl C, Haag J, Calaminus G, Klapper W Absence of BRAF mutation in pediatric and adolescent germ cell tumors indicate biological differences to adult tumors. Pediatric blood & cancer 2012, 59: 732    
Mashhadi MA, Heidari Z, Sepehri Z, Bakhshipour AR, Karimkoshte A The selenium status in thalassemia patients in South East of iran. Int J Hematol Oncol Stem Cell Res 2014 Oct 1; 8: 1    
Matthes-Martin S, Lion T, Aberle SW, Fritsch G, Lawitschka A, Bittner B, Frommlet F, Gadner H, Peters C Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality. Bone marrow transplantation 2003, 31: 803    
Mattke AC, Bailey EJ, Schuck A, Dantonello T, Leuschner I, Klingebiel T, Treuner J, Koscielniak E Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas? Pediatric blood & cancer 2009, 52: 772    
Mauz-Körholz C, Harms D, Calaminus G, Göbel U Primary chemotherapy and conservative surgery for vaginal yolk-sac tumour. Maligne Keimzelltumoren Study Group [letter]. Lancet 2000, 355    
Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D, Shankar A, Dörffel W, Wallace WH, Schellong G, Robert A, Körholz D, Oberlin O, Hall GW, Landman-Parker J Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 2007, 110: 179    
Mauz-Körholz C, Hasenclever D, Dörffel W, Ruschke K, Pelz T, Voigt A, Stiefel M, Winkler M, Vilser C, Dieckmann K, Karlén J, Bergsträsser E, Fosså A, Mann G, Hummel M, Klapper W, Stein H, Vordermark D, Kluge R, Körholz D Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study. Journal of clinical oncology 2010,    
Mauz-Körholz C, Hasenclever D, Holzendorf V, Bernstädt M, Jürgens H, Burdach S, Eggert A, Berthold F, Müller HL, Frühwald MC, Klingebiel T, Metzler M, Körholz D Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial. Leukemia & lymphoma 2014, 1    
Mauz-Körholz C, Lange T, Hasenclever D, Burkhardt B, Feller AC, Dörffel W, Kluge R, Vordermark D, Körholz D Pediatric Nodular Lymphocyte-predominant Hodgkin Lymphoma: Treatment Recommendations of the GPOH-HD Study Group. Klinische Padiatrie 2015, 227(6-7): 314    
Mauz-Körholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, Körholz D Pediatric Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Sep 20; 33: 2975    
Mavinkurve-Groothuis AM, van den Heuvel-Eibrink MM, Tytgat GA, van Tinteren H, Vujanic G, Pritchard-Jones KL, Howell L, Graf N, Bergeron C, Acha T, Catania S, Spreafico F Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG). Pediatric blood & cancer 2014, epub ahead of print    
Mayer B, Salama A Successful treatment of bleeding with tranexamic acid in a series of 12 patients with immune thrombocytopenia. Vox sanguinis 2017, 112: 767    
Mazloom A, Wolff JE, Paulino AC The impact of radiotherapy fields in the treatment of patients with choroid plexus carcinoma. Int J Radiat Oncol Biol Phys 2010, 78: 79    
Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, Ammour A, Broue P, Vial J, Ohanessian G, Léauté-Labrèze C, Labenne M, Vabres P, Rössler J, Bodemer C Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. The Journal of pediatrics 2010, 157: 340    
McGann PT, Nero AC, Ware RE Current management of sickle cell anemia. Cold Spring Harbor perspectives in medicine 2013, 3    
McIntosh N Medulloblastoma--a changing prognosis? Arch Dis Child 1979, 200    
Meadows AT, Obringer AC, Marrero O, Oberlin O, Robison L, Fossati-Bellani F, Green D, Voûte PA, Morris-Jones P, Greenberg M Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Medical and pediatric oncology 1989, 17: 477    
Meany HJ, London WB, Ambros PF, Matthay KK, Monclair T, Simon T, Garaventa A, Berthold F, Nakagawara A, Cohn SL, Pearson AD, Park JR Significance of clinical and biologic features in Stage 3 neuroblastoma: A report from the International Neuroblastoma Risk Group project. Pediatric blood & cancer 2014,    
Meerpohl JJ, Schell LK, Rücker G, Motschall E, Fleeman N, Niemeyer CM, Bassler D Deferasirox for managing transfusional iron overload in people with sickle cell disease. The Cochrane database of systematic reviews 2014, 5:CD007477    
Mehes G, Lorch T, Ambros P Quantitative analysis of disseminated tumor cells in the bone marrow by automated fluorescence image analysis. Cytometry 2000, 42: 357    
Mehes G, Luegmayr A, Ambros I, Ladenstein R, Ambros P Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow. Clin Cancer Res 2001, 7: 1969    
Mehes G, Luegmayr A, Hattinger C, Lorch T, Ambros I, Gadner H, Ambros P Automatic detection and genetic profiling of disseminated neuroblastoma cells. Med Pediatr Oncol 2001, 36: 205    
Mehren A, Azyurt J, Zu Klampen P, Boekhoff S, Thiel CM, Müller HL Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma. Journal of neuro-oncology 2018, 140: 27    
Meinert R, Kaatsch P, Kaletsch U, Krummenauer F, Miesner A, Michaelis J Childhood leukaemia and exposure to pesticides. Eur J Cancer 1996, 32A: 1943    
Meinert R, Kaletsch U, Kaatsch P, Schuz J, Michaelis J Associations between childhood cancer and ionizing radiation. Cancer Epidemiol Biomarkers Prev 1999, 8: 793    
Meinert R, Schuz J, Kaletsch U, Kaatsch P, Michaelis J Leukemia and non-Hodgkin's lymphoma in childhood and exposure to pesticides. Am J Epidemiol 2000, 151: 639    
Meissner B, Stanulla M, Ludwig W, Harbott J, Moricke A, Welte K, Schrappe M The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia. Leukemia 2004    
Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Klinische Padiatrie 2005 May-Jun; 217: 135    
Meissner B, Borkhardt A, Dilloo D, Fuchs D, Friedrich W, Handgretinger R, Peters C, Schrauder A, Schuster FR, Vormoor J, Maecker B, Sykora KW, Zintl F, Welte K, Sauer M Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia. Bone marrow transplantation 2007, 40: 945    
Meisel R, Dilloo D Pneumococcal vaccination of children after hematopoietic stem cell transplantation: timing is crucial. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2007 Aug 1; 45: 397-8; author reply 398    
Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Müller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nature genetics 2010, 42: 410    
Meinhardt A, Burkhardt B, Zimmermann M, Borkhardt A, Kontny U, Klingebiel T, Berthold F, Janka-Schaub G, Klein C, Kabickova E, Klapper W, Attarbaschi A, Schrappe M, Reiter A, Berlin-Frankfurt-Münster group Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia. Journal of clinical oncology 2010, 28: 3115    
Meier, Emily Riem, Miller, Jeffery L Sickle Cell Disease in Children. Drugs 2012, 72 : 895    
Melcher V, Graf M, Interlandi M, Moreno N, de Faria FW, Kim SN, Kastrati D, Korbanka S, Alfert A, Gerߟ J, Meyer Zu Hörste G, Hartmann W, Frühwald MC, Dugas M, Schüller U, Hasselblatt M, Albert TK, Kerl K Macrophage-tumor cell interaction promotes ATRT progression and chemoresistance. Acta neuropathologica 2020, 139: 913    
Menke-Moellers I, Berthold F In Vitro Sensitivity of Human Neuroblastoma Cells to Antineoplastic Drugs. Am J Pediatr Hematol Oncol 1993, 15: 47    
Mertens R, Lassay L, Heimann G Combined treatment of nasopharyngeal cancer in children and adolescents--concept of a study. Klinische Padiatrie 1993, 205: 241    
Merchant TE, Haida T, Wang MH, Finlay JL, Leibel SA Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 1997, 86: 943    
Mertens R, Granzen B, Lassay L, Gademann G, Hess CF, Heimann G Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie. Cancer 1997, 80: 951    
Merchant TE, Mulhern RK, Krasin MJ, Kun LE, Williams T, Li C, Xiong X, Khan RB, Lustig RH, Boop FA, Sanford RA Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Aug 1; 22: 3156    
Merchant TE, Fouladi M Ependymoma: new therapeutic approaches including radiation and chemotherapy. Journal of neuro-oncology 2005, 75: 287    
Mertens R, Granzen B, Lassay L, Bucsky P, Hundgen M, Stetter G, Heimann G, Weiss C, Hess CF, Gademann G Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH). Cancer 2005, 104: 1083    
Mertens R, Lassay L Seltene Tumoren, In: Gadner H, Gaedicke G, Niemeyer CH, Ritter J (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag 2006, 950    
Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. The Lancet. Oncology 2009, 10: 258    
Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, Joensuu T, van Leeuwen FE, van't Veer MB, Curtis RE, Holowaty EJ, Andersson M, Wiklund T, Gospodarowicz M, Travis LB Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000, 18: 2435    
Metzler M, Brehm U, Langer T, Viehmann S, Borkhardt A, Stanulla M, Schrappe M, Harbott J, Beck J, Rascher W, Repp R Asymmetric multiplex-polymerase chain reaction - a high throughput method for detection and sequencing genomic fusion sites in t(4;11). Br J Haematol 2004, 124: 47    
Metzler M, Strissel P, Strick R, Niemeyer C, Roettgers S, Borkhardt A, Harbott J, Ludwig W, Stanulla M, Schrappe M, Reinhardt D, Creutzig U, Beck J, Rascher W, Repp R, Langer T Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 2004, 41: 291    
Meyer LH, Queudeville M, Eckhoff SM, Creutzig U, Reinhardt D, Karawajew L, Ludwig WD, Stahnke K, Debatin KM Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML. Blood 2008, 111: 2899    
Meyer C, Kowarz E, Hofmann J, Renneville A, Zuna J, Trka J, Ben Abdelali R, Macintyre E, De Braekeleer E, De Braekeleer M, Delabesse E, de Oliveira MP, Cavé H, Clappier E, van Dongen JJ, Balgobind BV, van den Heuvel-Eibrink MM, Beverloo HB, Panzer-Grümayer R, Teigler-Schlegel A, Harbott J, Kjeldsen E, Schnittger S, Koehl U, Gruhn B, Heidenreich O, Chan LC, Yip SF, Krzywinski M, Eckert C, Möricke A, Schrappe M, Alonso CN, Schäfer BW, Krauter J, Lee DA, Zur Stadt U, Te Kronnie G, Sutton R, Izraeli S, Trakhtenbrot L, Lo Nigro L, Tsaur G, Fechina L, Szczepanski T, Strehl S, Ilencikova D, Molkentin M, Burmeister T, Dingermann T, Klingebiel T, Marschalek R New insights to the MLL recombinome of acute leukemias. Leukemia 2009, 23: 1490    
Meyer LH, Eckhoff SM, Queudeville M, Kraus JM, Giordan M, Stursberg J, Zangrando A, Vendramini E, Möricke A, Zimmermann M, Schrauder A, Lahr G, Holzmann K, Schrappe M, Basso G, Stahnke K, Kestler HA, Te Kronnie G, Debatin KM Early relapse in all is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways. Cancer Cell 2011, 19: 206    
Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, Pombo de Oliveira M, Renneville A, Villarese P, Macintyre E, Cavé H, Clappier E, Mass-Malo K, Zuna J, Trka J, De Braekeleer E, De Braekeleer M, Oh SH, Tsaur G, Fechina L, van der Velden VH, van Dongen JJ, Delabesse E, Binato R, Silva ML, Kustanovich A, Aleinikova O, Harris MH, Lund-Aho T, Juvonen V, Heidenreich O, Vormoor J, Choi WW, Jarosova M, Kolenova A, Bueno C, Menendez P, Wehner S, Eckert C, Talmant P, Tondeur S, Lippert E, Launay E, Henry C, Ballerini P, Lapillone H, Callanan MB, Cayuela JM, Herbaux C, Cazzaniga G, Kakadiya PM, Bohlander S, Ahlmann M, Choi JR, Gameiro P, Lee DS, Krauter J, Cornillet-Lefebvre P, Te Kronnie G, Schäfer BW, Kubetzko S, Alonso CN, Zur Stadt U, Sutton R, Venn NC, Izraeli S, Trakhtenbrot L, Madsen HO, Archer P, Hancock J, Cerveira N, Teixeira MR, Lo Nigro L, Möricke A, Stanulla M, Schrappe M, Sedék L, Szczepański T, Zwaan CM, Coenen EA, van den Heuvel-Eibrink MM, Strehl S, Dworzak M, Panzer-Grümayer R, Dingermann T, Klingebiel T, Marschalek R The MLL recombinome of acute leukemias in 2013. Leukemia 2013, Epub ahead of print    
Meyr F, Escherich G, Mann G, Klingebiel T, Kulozik A, Rossig C, Schrappe M, Henze G, von Stackelberg A, Hitzler J Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome. British journal of haematology 2013, Epub ahead of print    
Miano M, Labopin M, Hartmann O, Angelucci E, Cornish J, Gluckman E, Locatelli F, Fischer A, Egeler RM, Or R, Peters C, Ortega J, Veys P, Bordigoni P, Iori AP, Niethammer D, Rocha V, Dini G, Paediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone marrow transplantation 2007, 39: 89    
Michaelis J, Kaatsch P Use of information from clinical trials for an integrated cancer registry. Methods Inf Med 1990, 29: 92    
Michaelis J, Haaf G, Kaatsch P, Keller B Krebserkrankungen im Kindesalter in der Umgebung westdeutscher kerntechnischer Anlagen. Deutsches Ärzteblatt 1992, 2538    
Michaelis J, Keller B, Haaf G, Kaatsch P Incidence of childhood malignancies in the vicinity of west German nuclear power plants. Cancer Causes Control 1992, 3: 255    
Michaelis J, Kaatsch P, Zöllner I Querschnittsuntersuchung zur Häufigkeit von Krebserkrankungen bei Kindern von beruflich strahlenexponierten Beschäftigten in westdeutschen kerntechnischen Anlagen. Arbeitsmed Sozialmed Umweltmed 1995, 29 und 30: 29 30 -29    
Michaelis J, Haaf H, Zollner J, Kaatsch P, Krummenauer F, Berthold F Case control study of neuroblastoma in west-Germany after the Chernobyl accident. Klin Pädiatr 1996, 208: 172    
Michaelis J, Kaatsch P Krebs bei Kindern - Das Deutsche Kinderkrebsregister als Instrument der Krebsbekämpfung. Zeitschrift des Deutschen Krebsforschungszentrums 1996, 8    
Michaelis J, Kaletsch U, Burkart W, Grosche B Infant leukaemia after the Chernobyl accident. Nature 1997, 387    
Michaelis J, Schuz J, Meinert R, Menger M, Grigat J, Kaatsch P, Kaletsch U, Miesner A, Stamm A, Brinkmann K, Karner H Childhood leukemia and electromagnetic fields. Cancer Causes Control 1997, 8: 167    
Michaelis J Recent epidemiological studies on ionizing radiation and childhood cancer in Germany. Int J Radiat Biol 1998, 73: 377    
Michaelis J, Schuz J, Meinert R, Zemann E, Grigat J, Kaatsch P, Kaletsch U, Miesner A, Brinkmann K, Kalkner W, Karner H Combined risk estimates for two German population-based case-control studies on residential magnetic fields and childhood acute leukemia. Epidemiology 1998, 9: 92    
Michaelis J, Kaatsch P, Kaletsch U Leukämien im Kindesalter-Epidemiologische Untersuchungen des Deutschen Kinderkrebsregisters. Deutsches Ärzteblatt 1999, 918    
Michaelis J, Kaletsch U, Kaatsch P Epidemiology of childhood brain tumors. Zentralbl Neurochir 2000, 61: 80    
Mielcarek M, Sperling C, Schrappe M, Meyer U, Riehm H, Ludwig W Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia. Br J Haematol 1997, 96: 301    
Miller DR Hematologic malignancies: leukemia and lymphoma. Mosby Company, St. Louis, Philadelphia, Washington DC, Toronto 6th edition, 1990, 604    
Mild G, Schmahl G, Shayan P, Niemeyer C Expression of interferon regulatory factor 1 and 2 in hematopoietic cells of children with juvenile myelomonocytic leukemia. Leuk Lymphoma 1999, 35: 507    
Mildenberger H, Schweinitz D Lebertumore im Kindesalter. Monatsschr Kinderheilkunde 2000, 143: 644    
Milman N Anemia--still a major health problem in many parts of the world!. Ann Hematol 2011, 90: 369    
Minkov M, Grois N, Broadbent V, Ceci A, Jakobson A, Ladisch S Cyclosporine A therapy for multisystem langerhans cell histiocytosis. Med Pediatr Oncol 1999, 33: 482    
Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies In Process Citation. Klin Pädiatr 2000, 212: 139    
Minkov M, Grois N, Heitger A, Pötschger U, Westermeier T, Gadner H, DAL-HX Study Group Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Medical and pediatric oncology 2002, 39: 581    
Minkov M, Prosch H, Steiner M, Grois N, Pötschger U, Kaatsch P, Janka-Schaub G, Gadner H Langerhans cell histiocytosis in neonates. Pediatric blood & cancer 2005, 45: 802    
Minkov M, Pötschger U, Grois N, Gadner H, Dworzak MN Bone marrow assessment in Langerhans cell histiocytosis. Pediatric blood & cancer 2007, 49: 694    
Minkov M, Steiner M, Pötschger U, Aricò M, Braier J, Donadieu J, Grois N, Henter JI, Janka G, McClain K, Weitzman S, Windebank K, Ladisch S, Gadner H, International LCH Study Group Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry. The Journal of pediatrics 2008, 153: 700-5, 705.e1    
Minniti CP, Kato GJ Critical Reviews: How we treat sickle cell patients with leg ulcers. American journal of hematology 2015,    
Minkov M, Rodriguez-Galindo C Treatment of Langerhans cell histiocytosis: it is time to learn from the past. Br J Haematol 2015, 171: 148    
Mirow C, Pietsch T, Berkefeld S, Kwiecien R, Warmuth-Metz M, Falkenstein F, Diehl B, von Hornstein S, Gnekow AK Children <1 year show an inferior outcome when treated according to the traditional LGG treatment strategy: a report from the German multicenter trial HIT-LGG 1996 for children with low grade glioma (LGG). Pediatric blood & cancer 2014, 61: 457    
Mittheisz E, Seidl R, Prayer D, Waldenmair M, Neophytou B, Pötschger U, Minkov M, Steiner M, Prosch H, Wnorowski M, Gadner H, Grois N Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis. Pediatric blood & cancer 2007, 48: 50    
Mitchell L, Lambers M, Flege S, Kenet G, Li-Thiao-Te V, Holzhauer S, Bidlingmaier C, Frühwald MC, Heller C, Schmidt W, Pautard B, Nowak-Göttl U Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood 2010, 115: 4999    
Modritz D, Ladenstein R, Potschger U, Amman G, Dieckmann K, Horcher E, Urban C, Meister B, Schmitt K, Jones R, Kaulfersch W, Haas H, Moser R, Stollinger O, Peham M, Gadner H, Koscielniak E, Treuner J Treatment for soft tissue sarcoma in childhood and adolescence. Austrian results within the CWS 96 study. Wiener klinische Wochenschrift 2005, 117(5-6): 196    
Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M, Löning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M, German-Austrian-Swiss ALL-BFM Study Group Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008, 111: 4477    
Möricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, Ludwig WD, Ritter J, Harbott J, Mann G, Klingebiel T, Zintl F, Niemeyer C, Kremens B, Niggli F, Niethammer D, Welte K, Stanulla M, Odenwald E, Riehm H, Schrappe M Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2010, 24: 265    
Möricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, Ludwig WD, Ritter J, Harbott J, Mann G, Klingebiel T, Zintl F, Niemeyer C, Kremens B, Niggli F, Niethammer D, Welte K, Stanulla M, Odenwald E, Riehm H, Schrappe M Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia : 2010, 24: 265    
Möricke A, Lauten M, Beier R, Odenwald E, Stanulla M, Zimmermann M, Attarbaschi A, Niggli F, Schrappe M Prediction of Outcome by Early Response in Childhood Acute Lymphoblastic Leukemia. Klinische Padiatrie 2013, 225(S 01):S50-S56    
Möricke A, Zimmermann M, Valsecchi MG, Stanulla M, Biondi A, Mann G, Locatelli F, Cazzaniga G, Niggli F, Aricò M, Bartram CR, Attarbaschi A, Silvestri D, Beier R, Basso G, Ratei R, Kulozik AE, Lo Nigro L, Kremens B, Greiner J, Parasole R, Harbott J, Caruso R, von Stackelberg A, Barisone E, Rössig C, Conter V, Schrappe M Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood 2016, 127: 2101    
Moenen FCJI, Vries MJA, Nelemans PJ, van Rooy KJM, Vranken JRRA, Verhezen PWM, Wetzels RJH, Ten Cate H, Schouten HC, Beckers EAM, Henskens YMC Screening for platelet function disorders with Multiplate and platelet function analyzer. Platelets 2019, 30: 81    
Moll AC, Imhof SM, Schouten-Van Meeteren AY, Kuik DJ, Hofman P, Boers M Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk? Ophthalmology 2001, 108: 1109    
Molenaar JJ, Domingo-Fernández R, Ebus ME, Lindner S, Koster J, Drabek K, Mestdagh P, van Sluis P, Valentijn LJ, van Nes J, Broekmans M, Haneveld F, Volckmann R, Bray I, Heukamp L, Sprüssel A, Thor T, Kieckbusch K, Klein-Hitpass L, Fischer M, Vandesompele J, Schramm A, van Noesel MM, Varesio L, Speleman F, Eggert A, Stallings RL, Caron HN, Versteeg R, Schulte JH LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet 2012, 44: 1199    
Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD, INRG Task Force The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. Journal of clinical oncology 2009, 27: 298    
Monje M, Fisher PG Neurological complications following treatment of children with brain tumors. Journal of pediatric rehabilitation medicine 2011, 4: 31    
Morrell D, Cromartie E, Swift M Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 1986, 77: 89    
Moricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dordelmann M, Loning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008, 111: 4477    
Morris B, Partap S, Yeom K, Gibbs IC, Fisher PG, King AA Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report. Neurology 2009 Dec 1; 73: 1906    
Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, Cant AJ, Thrasher AJ, Cowan MJ, Albert MH, Small T, Pai SY, Haddad E, Lisa A, Hambleton S, Slatter M, Cavazzana-Calvo M, Mahlaoui N, Picard C, Torgerson TR, Burroughs L, Koliski A, Neto JZ, Porta F, Qasim W, Veys P, Kavanau K, Hönig M, Schulz A, Friedrich W, Notarangelo LD Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood 2011 Aug 11; 118: 1675    
Morgenstern DA, London WB, Stephens D, Volchenboum SL, Simon T, Nakagawara A, Shimada H, Schleiermacher G, Matthay KK, Cohn SL, Pearson AD, Irwin MS Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database. European journal of cancer (Oxford, England : 1990) 2016, 65: 1    
Moreno L, Caron H, Geoerger B, Eggert A, Schleiermacher G, Brock P, Valteau-Couanet D, Chesler L, Schulte JH, De Preter K, Molenaar J, Schramm A, Eilers M, Van Maerken T, Johnsen JI, Garrett M, George SL, Tweddle DA, Kogner P, Berthold F, Koster J, Barone G, Tucker ER, Marshall L, Herold R, Sterba J, Norga K, Vassal G, Pearson AD Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project. Expert opinion on drug discovery 2017, 12: 801    
Morales JS, Valenzuela PL, Rincón-Castanedo C, Takken T, Fiuza-Luces C, Santos-Lozano A, Lucia A Exercise training in childhood cancer: A systematic review and meta-analysis of randomized controlled trials. Cancer treatment reviews 2018, 70: 154    
Moskowitz CH, Nademanee A, Masszi T, Agura E, Holowiecki J, Abidi MH, Chen AI, Stiff P, Gianni AM, Carella A, Osmanov D, Bachanova V, Sweetenham J, Sureda A, Huebner D, Sievers EL, Chi A, Larsen EK, Hunder NN, Walewski J, AETHERA Study Group Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England) 2015 May 9; 385: 1853    
Müller H Warum brauchen manche Hirntumorpatienten Hormone, obwohl ihre Drüsen gesund sind? WIR Informationsschrift der Aktion für krebskranke Kinder e.V. (Bonn) 2006, 2: 12    
Müller HL, Gebhardt U, Pohl F, Flentje M, Emser A, Warmuth-Metz M, Kolb R, Calaminus G, Sörensen N Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma. Klin Pädiatr 2006, 218: 315-20.    
Müller HL, Albanese A, Calaminus G, Hargrave D, Garré ML, Gebhardt U, Saran F, Sörensen N, Spoudeas HA Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004. J Pediatr Endocrinol Metab 2006, 19 Suppl 1: 453    
Mühlisch J, Schwering A, Grotzer M, Vince GH, Roggendorf W, Hagemann C, Sörensen N, Rickert CH, Osada N, Jürgens H, Früwald MC Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. Oncogene 2006, 25: 1111    
Müller HL, Gebhardt U, Wessel V, Schröder S, Kolb R, Sörensen N, Maroske J, Hanisch E First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin padiatr 2007, 219: 323-5.    
Müller HL Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 2008, 69: 193    
Müller HL, Sörensen N Kraniopharyngiom im Kindes- und Jugendalter. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Gesellschaft für Pädiatrische Onkologie und Hämatologie AWMF online 2008    
Müller HL Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. nt J Endocrinol 2010, 2010, 519607    
Müller HL Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up. Expert Rev Neurother 2010, 10: 515    
Müller HL, Gebhardt U, Schröder S, Pohl F, Kortmann RD, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Calaminus G, Kolb R, Wiegand C, Sörensen N, study committee of KRANIOPHARYNGEOM 2000/2007 Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr 2010, 73: 175    
Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sörensen N, Calaminus G, the study committee of KRANIOPHARYNGEOM 2000 Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 2011, 165: 17    
Müller HL Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab 2011, 96: 1981    
Müller K, Zwiener I, Welker H, Maaß E, Bongartz R, Berthold F, Pietsch T, Warmuth-Metz M, von Bueren A, Rutkowski S Curative treatment for central nervous system medulloepithelioma despite residual disease after resection : Report of two cases treated according to the GPHO protocol HIT 2000 and review of the literature. Strahlentherapie und Onkologie 2011,Epub ahead of print    
Müller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, Pohl F, Calaminus G, Sörensen N, Kraniopharyngeom 2000 Study Committee Xanthogranuloma, Rathke's cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. The Journal of clinical endocrinology and metabolism 2012, 97: 3935    
Müller K, Gnekow A, Falkenstein F, Scheiderbauer J, Zwiener I, Pietsch T, Warmuth-Metz M, Voges J, Nikkhah G, Flentje M, Combs SE, Vordermark D, Kocher M, Kortmann RD Radiotherapy in pediatric pilocytic astrocytomas : A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH). Strahlentherapie und Onkologie 2013, 189: 647    
Müller K, Schlamann A, Seidel C, Warmuth-Metz M, Christiansen H, Vordermark D, Kortmann RD, Kramm CM, von Bueren AO Craniospinal irradiation with concurrent temozolomide and nimotuzumab in a child with primary metastatic diffuse intrinsic pontine glioma : A compassionate use treatment. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2013, 189: 693    
Müller HL Paediatrics: Surgical strategy and quality of life in craniopharyngioma. Nature reviews. Endocrinology 2013, 9: 447    
Mueller S, Fullerton HJ, Stratton K, Leisenring W, Weathers RE, Stovall M, Armstrong GT, Goldsby RE, Packer RJ, Sklar CA, Bowers DC, Robison LL, Krull KR Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. International journal of radiation oncology, biology, physics 2013 Jul 15; 86: 649    
Müller CR, Mytilineos J, Ottinger H, Arnold R, Bader P et al. Deutscher Konsensus 2013 zur immungenetischen Spenderauswahl für die allogene Stammzelltransplantation. Empfehlungen der Deutschen Gesellschaft für Immungenetik DGI 2013    
Müller K, Schlamann A, Guckenberger M, Warmuth-Metz M, Glück A, Pietschmann S, Wawer A, Kortmann RD, Kramm C, von Bueren AO Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group. Strahlentherapie und Onkologie 2014, 190: 377    
Müller K, Scheithauer H, Pietschmann S, Hoffmann M, Rössler J, Graf N, Baumert BG, Christiansen H, Kortmann RD, Kramm CM, von Bueren AO Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group. Radiation oncology 2014, 9: 177    
Mueller HL Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome. Endocrine 2016, 51: 1    
Mueller HL Craniopharyngioma: long-term consequences of a chronic disease. Expert review of neurotherapeutics 2015, 15: 1241    
Mueller HL Risk-adapted treatment and follow-up management in childhood-onset craniopharyngioma. Expert review of neurotherapeutics 2016, 16: 535    
Mueller HL Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Current opinion in endocrinology, diabetes, and obesity 2016, 23: 81    
Mueller HL Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients. Minerva endocrinologica 2017, 42: 356    
Mueller HL, Merchant TE, Puget S, Martinez-Barbera JP New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nature reviews. Endocrinology 2017, 13: 299    
Mueller HL Risk-adapted, long-term management in childhood-onset craniopharyngioma. Pituitary 2017, 20: 267    
Mueller I, Ehlert K, Endres S, Pill L, Siebert N, Kietz S, Brock P, Garaventa A, Valteau-Couanet D, Janzek E, Hosten N, Zinke A, Barthlen W, Varol E, Loibner H, Ladenstein R, Lode HN Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14. 18/CHO. mAbs 2018, 10: 55    
Müller HL, Merks JHM, Geoerger B, Grill J, Hargrave D, Glade Bender J, Gururangan S, Navid F, Johnston M, Bachir J, Elze MC, Fürst-Recktenwald S Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumab. Pediatric blood & cancer 2019, 66:e27487    
Müller HL, Reichel J, Boekhoff S, Warmuth-Metz M, Eveslage M, Peng J, Flitsch J Low concordance between surgical and radiological assessment of degree of resection and treatment-related hypothalamic damage: results of KRANIOPHARYNGEOM 2007. Pituitary 2018, 21: 371    
Müller HL Hypothalamic involvement in craniopharyngioma-Implications for surgical, radiooncological, and molecularly targeted treatment strategies. Pediatric blood & cancer 2018, 65:e26936    
Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S Craniopharyngioma. Nature reviews. Disease primers 2019, 5: 75    
Müller HL The Diagnosis and Treatment of Craniopharyngiomas. Neuroendocrinology 2019,Epub ahead of print    
Müller HL MANAGEMENT OF ENDOCRINE DISEASE: Childhood-onset craniopharyngioma: state of the art of care in 2018. European journal of endocrinology 2019, 180:R159-R174    
Müller HL Reply to: Understanding treatment options in craniopharyngioma better. Nature reviews. Disease primers 2020, 6: 27    
Muller J, Diallo R, Schaefer K, Lanvers C, Schuck A, Ahrens S, Willich N, Jürgens H, Poremba C Prognostic factors in Ewing tumors assessed by tissue microarray technology. Klin Pädiatr 2002, 214    
Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE Late neurocognitive sequelae in survivors of brain tumours in childhood. The Lancet. Oncology 2004, 5: 399    
Mulla H, Buck H, Price L, Parry A, Bell G, Skinner R 'Acceptability' of a new oral suspension formulation of mercaptopurine in children with acute lymphoblastic leukaemia. J Oncol Pharm Practice 0 1    
Murphy SB Classification, staging and end results of treatment of childhood non-Hodgkins-lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 1980, 7: 332    
Linn Murphree A Intraocular retinoblastoma: the case for a new group classification. Ophthalmology clinics of North America 2005, 18: 41-53, viii    
Musial-Bright L, Fengler R, Henze G, Hernáiz Driever P Carboplatin and ototoxicity: hearing loss rates among survivors of childhood medulloblastoma. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2011, 27: 407    
Myers K, Davies SM, Harris RE, Spunt SL, Smolarek T, Zimmerman S, McMasters R, Wagner L, Mueller R, Auerbach AD, Mehta PA The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations. Pediatric blood & cancer 2012, 58: 462    
Mynarek M, Bettoni da Cunha Riehm C, Brinkmann F, Weißenborn K, Tell-Lüersen M, Heuft HG, Maecker-Kolhoff B, Sykora KW Normalized Transcranial Doppler Velocities, Stroke Prevention and Improved Pulmonary Function after Stem Cell Transplantation in Children with Sickle Cell Anemia. Klinische Padiatrie 2013, 225: 127    
Mynarek M, Pizer B, Dufour C, van Vuurden D, Garami M, Massimino M, Fangusaro J, Davidson T, Gil-da-Costa MJ, Sterba J, Benesch M, Gerber N, Juhnke BO, Kwiecien R, Pietsch T, Kool M, Clifford S, Ellison DW, Giangaspero F, Wesseling P, Gilles F, Gottardo N, Finlay JL, Rutkowski S, von Hoff K Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data. Neuro-oncology 2017 Apr 1; 19: 576    
Mynarek M, von Hoff K, Pietsch T, Ottensmeier H, Warmuth-Metz M, Bison B, Pfister S, Korshunov A, Sharma T, Jaeger N, Ryzhova M, Zheludkova O, Golanov A, Rushing EJ, Hasselblatt M, Koch A, Schüller U, von Deimling A, Sahm F, Sill M, Riemenschneider MJ, Dohmen H, Monoranu CM, Sommer C, Staszewski O, Mawrin C, Schittenhelm J, Brück W, Filipski K, Hartmann C, Meinhardt M, Pietschmann K, Haberler C, Slavc I, Gerber NU, Grotzer M, Benesch M, Schlegel PG, Deinlein F, von Bueren AO, Friedrich C, Juhnke BO, Obrecht D, Fleischhack G, Kwiecien R, Faldum A, Kortmann RD, Kool M, Rutkowski S Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort. Journal of clinical oncology 2020, JCO1903057    
Müller HL Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol 2010, 6: 609    
Müller H, Fruhwald M, Scheubeck M, Rendl J, Warmuth-Metz M, Sörensen N, Kühl J, Reubi J A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma. J Neurooncol 1998, 38: 27    
Müller-Berghaus J, Kurowski C, Gharib M, Engelskirchen R, Roth B, Berthold F Artificial abdominal hernia for the treatment of hepatomegaly in a neonate with stage 4S neuroblastoma. Pediatr Hematol Oncol 1999, 16: 453    
Müller H, Loning L, Horn A, Schwabe D, Gunkel M, Schrappe M, von Schutz V, Henze G, Casimiro da, Ritter J, Pinheiro J, Winkelhorst M, Boos J Pegylated asparaginase (Oncaspar) in children with ALL. Br J Haematol 2000, 110: 379    
Müller-Berghaus J, Berthold F Neuroblastom in Poliwoda H, Link H (Hrsg.) Kompendium der Hämatologie / Onkologie 2000    
Müller H, Beier R, Loning L, Blutters-Sawatzki R, Dörffel W, Maass E, Muller-Weihrich S, Scheel-Walter H, Scherer F, Stahnke K, Schrappe M, Horn A, Lumkemann K, Boos J Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment. Br J Haematol 2001, 114: 794    
Müller H, Beier R, da Palma J, Lanvers C, Ahlke E, von Schutz V, Gunkel M, Horn A, Schrappe M, Henze G, Kranz K, Boos J PEG-asparaginase (Oncaspar) 2500 U/m2 BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols. Cancer Chemother Pharmacol 2002, 49: 149    
188 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.